Relationship of maternal cytomegalovirus-specific antibody responses and viral load to vertical transmission risk following primary maternal infection in a rhesus macaque model
PLOS Pathogens · 2023
DOI: 10.1371/journal.ppat.1011378 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Claire E Otero und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Duke University, Durham, North Carolina, United States of America. Hauptthemen laut MEDLINE: Cytomegalovirus, Cytomegalovirus Infections. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Cytomegalovirus (CMV) is the most common congenital infection and cause of birth defects worldwide. Primary CMV infection during pregnancy leads to a higher frequency of congenital CMV (cCMV) than maternal re-infection, suggesting that maternal immunity confers partial protection. However, poorly understood immune correlates of protection against placental transmission contributes to the current lack of an approved vaccine to prevent cCMV. In this study, we characterized the kinetics of maternal plasma rhesus CMV (RhCMV) viral load (VL) and RhCMV-specific antibody binding and functional responses in a group of 12 immunocompetent dams with acute, primary RhCMV infection. We defined cCMV transmission as RhCMV detection in amniotic fluid (AF) by qPCR. We then leveraged a large group of past and current primary RhCMV infection studies in late-first/early-second trimester RhCMV-seronegative rhesus macaque dams, including immunocompetent (n = 15), CD4+ T cell-depleted with (n = 6) and without (n = 6) RhCMV-specific polyclonal IgG infusion before infection to evaluate differences between RhCMV AF-positive and AF-negative dams. During the first 3 weeks after infection, the magnitude of RhCMV VL in maternal plasma was higher in AF-positive dams in the combined cohort, while RhCMV glycoprotein B (gB)- and pentamer-specific binding IgG responses were lower magnitude compared to AF-negative dams. However, these observed differences were driven by the CD4+ T cell-depleted dams, as there were no differences in plasma VL or antibody responses between immunocompetent AF-positive vs AF-negative dams. Overall, these results suggest that levels of neither maternal plasma viremia nor humoral responses are associated with cCMV following primary maternal infection in healthy individuals. We speculate that other factors related to innate immunity are more important in this context as antibody responses to acute infection likely develop too late to influence vertical transmission. Yet, pre-existing CMV glycoprotein-specific and neutralizing IgG may provide protection against cCMV following primary maternal CMV infection even in high-risk, immunocompromised settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Duke University, Durham, North Carolina, United States of America.
- Department of Pediatrics, Weill Cornell Medical College, New York, New York, United States of America.
- Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, United States of America.
- Tulane National Primate Research Center, Covington, Louisiana, United States of America.
- Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
- Duke Human Vaccine Institute & Department of Surgery, Duke University, Durham, North Carolina, United States of America.
ORCID-Profile: Sallie R Permar
Förderung
- NIH HHS
- NCI NIH HHS
- NIAID NIH HHS
- NICHD NIH HHS
- NCATS NIH HHS
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- NIH/NICHD
- National Cancer Institute
Zitieren
APA
Otero, C. E., Barfield, R., Scheef, E., Nelson, C. S., Rodgers, N., Wang, H. Y., Moström, M. J., Manuel, T. D., Sass, J., Schmidt, K., Taher, H., Papen, C., Sprehe, L., Kendall, S., Davalos, A., Barry, P. A., Früh, K., Pollara, J., Malouli, D., …, & Permar, S. R. (2023). Relationship of maternal cytomegalovirus-specific antibody responses and viral load to vertical transmission risk following primary maternal infection in a rhesus macaque model. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011378
Vancouver
Otero CE, Barfield R, Scheef E, Nelson CS, Rodgers N, Wang HY, et al. Relationship of maternal cytomegalovirus-specific antibody responses and viral load to vertical transmission risk following primary maternal infection in a rhesus macaque model. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011378
BibTeX
@article{Otero2023,
author = {Otero, Claire E and Barfield, Richard and Scheef, Elizabeth and Nelson, Cody S and Rodgers, Nicole and Wang, Hsuan-Yuan and Moström, Matilda J and Manuel, Tabitha D and Sass, Julian and Schmidt, Kimberli and Taher, Husam and Papen, Courtney and Sprehe, Lesli and Kendall, Savannah and Davalos, Angel and Barry, Peter A and Früh, Klaus and Pollara, Justin and Malouli, Daniel and Chan, Cliburn and Kaur, Amitinder and Permar, Sallie R},
title = {Relationship of maternal cytomegalovirus-specific antibody responses and viral load to vertical transmission risk following primary maternal infection in a rhesus macaque model},
journal = {PLOS Pathogens},
year = {2023},
doi = {10.1371/journal.ppat.1011378}
}
EUVIMED